Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications

Shane Bowen's Biography

Shane Bowen, Director, Scientific Research; Dept. of Research & Technology Development, Illumina

Shane Bowen received his B.S. in Physics (Honors) and Mathematics from the University of San Francisco in 1998. In 2000 he completed his M.S. in Applied Physics and in 2005 his Ph.D. in Physical Chemistry, both from the University of California, San Diego. Following two years working within the flat panel display industry as a System Scientist for a Joint Venture between Cymer Lasers (now ASML) and Carl Zeiss SMT, he joined illumina in 2007. Over the last decade, Shane has progressed from being an individual contributor working on both genotyping and sequencing platforms to now serving as the lead of the Nanofabrication division within the department of Research and Technology Development. The work that Shane’s group focuses on today is the development of chemical patterning processes at the foundation of illumina’s flowcell technology as well as development of sensors to be used in future platforms for genetic analysis. Shane was awarded illumina’s innovation award in 2016 for the development of the patterned flowcelll technology at the foundation of the $1000 genome. At this time, Shane has more than fifteen published and granted patents and more than thirty pending publications.

Shane Bowen Image

Nanotechnology for a Genomic Revolution

Wednesday, 4 October 2017 at 13:30

Add to Calendar ▼2017-10-02 00:00:002017-10-02 01:00:00Europe/LondonTitle to be

Over the duration of the human genome project (HGP) from 1990 to 2003, more than $2.7 billion dollars was spent across 20 global institutions resulting in the cataloging of a human genome at 8 -9 X coverage. This was a monumental achievement completed through the use of hierarchical shotgun method, which set the foundation upon which modern methods of genetic analysis stand. Since the completion of the HGP, numerous efforts have been put forth to increase the accuracy, simplify the process reduce the amount of time and cost associated with measuring the sequence of any organism. This is now the foundation of modern medicine and is on the verge of a changing the way not only healthcare is performed but also revolutionizing agriculture, forensics and pharmaceutical development around the world. Over the years of 2009 through 2014, myself and a team of research scientists at Illumina developed a method to sequence a human genome in less than 48 hours at a coverage of 30X and at the cost of $1000. During this talk, I will give an overview of the technologies developed to make this happen as well as set the stage for the next iteration of innovations paving the path to the $100 genome, being enabled by the NovaSeq platform commercialized by Illumina this year.

Add to Calendar ▼2017-10-02 00:00:002017-10-04 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and